Combined nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab in the treatment of advanced melanoma (MEL) patients (pts): Safety and clinical activity Meeting Abstract
| Authors: | Sznol, M.; Callahan, M. K.; Kluger, H.; Postow, M. A.; Burke, M.; Hong, Q.; Selby, M.; Korman, A.; Gupta, A.; Wolchok, J. D. |
| Abstract Title: | Combined nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab in the treatment of advanced melanoma (MEL) patients (pts): Safety and clinical activity |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S866 |
| Language: | English |
| ACCESSION: | WOS:000326843605342 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70065-0 |
| Notes: | Meeting Abstract: 3734 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
